Emergency Medicine News

Researchers at the University of Washington and Seattle Children's found that using exclusion-based criteria to refer infants for genetic testing in the NICU led to more diagnoses and at earlier ages.

Senators questioned Jay Bhattacharya, MD, PhD, about proposed NIH cuts to biomedical research, the safety of vaccines, and government transparency during his nomination hearing Wednesday to be the next director of the NIH.

When Ashley Haugen and her husband Jonathan took their daughter to a dermatologist to get a skin tag removed, he pointed to a rash around her mouth and recommended the couple stop using harsh soaps until it clears up.

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more than 44 pounds, according to the manufacturer.

NSAIDs “provide the greatest benefit and least harm” for treating acute pain in children compared with ketamine and opioids, according to findings from a systematic review and meta-analysis published in JAMA Pediatrics.

Two AAP-recommended strategies can help physicians rule out invasive bacterial infections in febrile infants, which could reduce unnecessary lumbar punctures, but they were not as effective in younger infants, researchers found.

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets the immune checkpoint B7-H3 for diffuse intrinsic pontine glioma, or DIPG, a rare incurable pediatric brain tumor.

Two major policy updates were published in 2024 regarding opioids and children.

One in six hospitals that accepted pediatric patients in 2019 closed their pediatric services by 2021, according to a study published in JAMA Network Open.